GluR Antibodies

Santa Cruz Biotechnology features a diverse variety of GluR monoclonal antibodies for studying glutamate receptors, which play a crucial role in synaptic transmission and plasticity in the central nervous system. GluR monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GluR proteins are essential for mediating excitatory neurotransmission and are implicated in numerous neurological processes, including learning and memory. Dysregulation of glutamate receptors has been associated with various neurodegenerative diseases and psychiatric disorders, making them a significant focus of research. Understanding the function and regulation of GluR proteins is vital for developing therapeutic strategies targeting these pathways. Researchers worldwide rely on GluR monoclonal antibodies to explore the molecular mechanisms underlying neurological disorders. The specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies enable scientists to make meaningful discoveries in glutamate receptor research. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing neuroscience and developing potential treatments for neurological conditions.